Cargando…

Should COVID-19 be considered cardiovascular disease risk equivalent?

Detalles Bibliográficos
Autores principales: Kow, Chia Siang, Ramachandram, Dinesh Sangarran, Hasan, Syed Shahzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884400/
https://www.ncbi.nlm.nih.gov/pubmed/36724830
http://dx.doi.org/10.1016/j.ijcard.2023.01.076
_version_ 1784879710274060288
author Kow, Chia Siang
Ramachandram, Dinesh Sangarran
Hasan, Syed Shahzad
author_facet Kow, Chia Siang
Ramachandram, Dinesh Sangarran
Hasan, Syed Shahzad
author_sort Kow, Chia Siang
collection PubMed
description
format Online
Article
Text
id pubmed-9884400
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-98844002023-01-30 Should COVID-19 be considered cardiovascular disease risk equivalent? Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad Int J Cardiol Letter to the Editor Elsevier B.V. 2023-04-15 2023-01-29 /pmc/articles/PMC9884400/ /pubmed/36724830 http://dx.doi.org/10.1016/j.ijcard.2023.01.076 Text en © 2023 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Kow, Chia Siang
Ramachandram, Dinesh Sangarran
Hasan, Syed Shahzad
Should COVID-19 be considered cardiovascular disease risk equivalent?
title Should COVID-19 be considered cardiovascular disease risk equivalent?
title_full Should COVID-19 be considered cardiovascular disease risk equivalent?
title_fullStr Should COVID-19 be considered cardiovascular disease risk equivalent?
title_full_unstemmed Should COVID-19 be considered cardiovascular disease risk equivalent?
title_short Should COVID-19 be considered cardiovascular disease risk equivalent?
title_sort should covid-19 be considered cardiovascular disease risk equivalent?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884400/
https://www.ncbi.nlm.nih.gov/pubmed/36724830
http://dx.doi.org/10.1016/j.ijcard.2023.01.076
work_keys_str_mv AT kowchiasiang shouldcovid19beconsideredcardiovasculardiseaseriskequivalent
AT ramachandramdineshsangarran shouldcovid19beconsideredcardiovasculardiseaseriskequivalent
AT hasansyedshahzad shouldcovid19beconsideredcardiovasculardiseaseriskequivalent